Literature DB >> 32421903

HLA-DR-expressing NK cells: Effective killers suspected for antigen presentation.

Sofya A Erokhina1, Maria A Streltsova1, Leonid M Kanevskiy1, Maria V Grechikhina1, Alexander M Sapozhnikov1, Elena I Kovalenko1.   

Abstract

HLA-DR-expressing cells comprise an intriguing group of NK cells, which combine phenotypic characteristics of both NK cells and dendritic cells. These cells can be found in humans and mice; they are present in blood and tissues in healthy conditions and can expand in a spectrum of pathologies. HLA-DR+ NK cells are functionally active: they produce proinflammatory cytokines, degranulate, and easily proliferate in response to stimuli. Additionally, HLA-DR+ NK cells seem able to take in and then present certain antigens to CD4+ and CD8+ T cells, inducing their activation and proliferation, which puts them closer to professional antigen-presenting cells. It appears that these NK cells should be considerable players of the innate immune system, both due to their functional activity and regulation of the innate and adaptive immune responses. In this review, for the first time, we provide a detailed description and analysis of the available data characterizing phenotypic, developmental, and functional features of the HLA-DR+ NK cells in a healthy condition and a disease. ©2020 Society for Leukocyte Biology.

Entities:  

Keywords:  HLA-DR+ NK cells; IFN gamma; MHC class II; NK cell activation; antigen presentation

Mesh:

Substances:

Year:  2020        PMID: 32421903     DOI: 10.1002/JLB.3RU0420-668RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  7 in total

1.  Panoramic comparison between NK cells in healthy and cancerous liver through single-cell RNA sequencing.

Authors:  Huan Liu; Ronghua Zhao; Rongrong Qin; Haoyu Sun; Qiang Huang; Lianxin Liu; Zhigang Tian; Björn Nashan; Cheng Sun; Rui Sun
Journal:  Cancer Biol Med       Date:  2022-07-21       Impact factor: 5.347

Review 2.  Exploring the Utility of NK Cells in COVID-19.

Authors:  Xuewen Deng; Hiroshi Terunuma; Mie Nieda
Journal:  Biomedicines       Date:  2022-04-26

3.  Immunophenotyping of Peripheral Blood Mononuclear Cells in Septic Shock Patients With High-Dimensional Flow Cytometry Analysis Reveals Two Subgroups With Differential Responses to Immunostimulant Drugs.

Authors:  Ya Wang; Brian Gloss; Benjamin Tang; Suat Dervish; Brigitte Santner-Nanan; Christina Whitehead; Kristy Masters; Kristen Skarratt; Sally Teoh; Stephen Schibeci; Nicole Fewings; Chrystelle Brignone; Frederic Triebel; David Booth; Anthony McLean; Marek Nalos
Journal:  Front Immunol       Date:  2021-03-22       Impact factor: 7.561

4.  The Characteristics of Natural Killer Cells and T Cells Vary With the Natural History of Chronic Hepatitis B in Children.

Authors:  Yingzhi Zhou; Yi He; Yunan Chang; Xiaorong Peng; Ruiqiu Zhao; Mingli Peng; Peng Hu; Hong Ren; Min Chen; Hongmei Xu
Journal:  Front Pediatr       Date:  2021-11-25       Impact factor: 3.418

5.  Single-Cell Transcriptomics Reveals Peripheral Immune Responses in Anti-Synthetase Syndrome-Associated Interstitial Lung Disease.

Authors:  Lili Zhu; Zhong Cao; Shiyao Wang; Changshui Zhang; Lei Fang; Yanhong Ren; Bingbing Xie; Jing Geng; Sheng Xie; Ling Zhao; Li Ma; Huaping Dai; Chen Wang
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

Review 6.  Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma.

Authors:  Minjie Wang; Zijie Zhou; Xuan Wang; Chaocai Zhang; Xiaobing Jiang
Journal:  Cell Death Dis       Date:  2022-07-08       Impact factor: 9.685

7.  Natural killer cells-related immune traits and amyotrophic lateral sclerosis: A Mendelian randomization study.

Authors:  Zhenxiang Gong; Yang Liu; Fengfei Ding; Li Ba; Min Zhang
Journal:  Front Neurosci       Date:  2022-09-29       Impact factor: 5.152

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.